From: Coinfection of fungi with SARS-CoV-2 is a detrimental health risk for COVID-19 patients
Name of fungi | Morphology | Pathogenicity | Clinical manifestation | Symptoms | Diagnosis | References | |
---|---|---|---|---|---|---|---|
Black Fungi | Mucor spp. | 1. Saprophytic colonizers | Infection is assumed to spread by | Involved in creating infections to immunocompromised patients such as | Mucormycosis symptoms are mild and nonspecific, such as | Diagnosis is performed by | [56] |
2. Encompasses filamentous mycelium or budding yeast cells that are spherical | 1. Inhalation, traumatic inoculation or ingestion | 1. Pulmonary mucormycosis | 1. Chest discomfort | 1. Calcofluor white | |||
3. Contain branched sporangiospores | 2. Invasion of blood vessels, which results in tissue infarction, necrosis, and thrombosis | 2. Rhinocerebral mucormycosis | 2. Dyspnea | 2. Fluorescent in situ hybridization | |||
4. Contain rigid cell walls with the presence of cellulose or chitin | 3. Subcutaneous mucormycosis | 3. Fever | 3. Gomori methenamine silver stain | ||||
5. Cell wall consists of lipids, proteins, phosphates, amino sugars, Phosphorus, Magnesium, and Calcium | 4. Maxillofacial mucormycosis | 4. Headache | 4. Immunohistochemistry analysis | ||||
5. Gastrointestinal mucormycosis | 5. Fatigue | 5. Periodic acid–Schiff stain | |||||
6. Cough | 6. Wet mount | ||||||
7. Mucosal necrosis | 7. Conventional PCR | ||||||
8. Ophthalmologic abnormalities such as proptosis, ptosis, aphasia, and visual alterations | 8. DNA sequencing | ||||||
9. Nasal bridge or upper inside of black mouth lesions that rapidly worsen | 9. Real-time PCR | ||||||
10. Breathing problems | 10. Restriction fragment length polymorphism | ||||||
11. Infected skin might develop blisters or ulcers, and the region may turn black | 11. API ID32C and API ID50C | ||||||
12. Discomfort, warmth or redness or swelling surrounding the affected area | 12. ELIspot | ||||||
13. Bleeding in the digestive tract | 13. Computed tomography (CT) scan | ||||||
14. Stomachache | |||||||
Rhizopus spp. | Differ with Mucor spp. in having unbranched sporangiospores and having stolon | Infection is assumed to spread by | Involved in creating infections to immunocompromised patients such as | Rhizopus spp. also cause Mucormycosis; thus, the symptoms are the same | Diagnosis is carried out by- | ||
1. Inhalation, traumatic inoculation or ingestion | 1. Pulmonary mucormycosis | 1. Chest discomfort | 1. Computed tomography (CT) scan | ||||
2. Invasion of blood vessels, which results in tissue infarction, necrosis, and thrombosis | 2. Rhinocerebral mucormycosis | 2. Dyspnea | |||||
3. Subcutaneous mucormycosis | 3. Fever | ||||||
4. Maxillofacial mucormycosis | 4. Headache | ||||||
5. Gastrointestinal mucormycosis | 5. Fatigue | ||||||
6. Cough | |||||||
7. Skin blisters | |||||||
8. Stomach pain | |||||||
White Fungi | Aspergillus spp. | 1. Appear in velvety yellow to green or blue or brown mold | Infection routes are | Clinical significances are | Clinical signs and symptoms are | Diagnostic procedures are | [59] |
2. Comprise conidiophores that could be lengthy, rough, pitted, or spiny | 1. Respiratory route | 1. Chronic cavitary pulmonary aspergillosis and aspergilloma | 1. Anorexia | 1. Wet mount | |||
3. Conidiophores are either uniseriate or biseriate | 2. In tissue where hyphal growth forms | 2. Allergic bronchopulmonary aspergillosis | 2. Weight loss | 2. Gomori’s methenamine silver stain (GMS) | |||
4. Conidia are globose or subglobose, thorny and size varies from 3.5 to 4.5 µm in diameter | 3. Dissemination in extrapulmonary tissues | 3. Allergic fungal sinusitis | 3. Malaise | 3. Periodic acid–Schiff (PAS) | |||
5. Produces toxins | 4. Paranasal sinuses | 4. Rhinosinusitis | 4. Sweating | 4. Galactomannan (GM) detection in fluids | |||
5. Fungal colonization in the gastrointestinal tract at the sites of the cornea | 5. Cutaneous infection | 5. Fever | 5. Early bronchoalveolar lavage (BAL) | ||||
6. Central nervous system infection | 6. Persistent productive cough | 6. CT scan | |||||
7. Dyspnea | 7. Thin-section chest computed tomography | ||||||
8. Chest pain | 8. Multidetector computed tomography (MDCT) | ||||||
9. Rare occasional hemoptysis | 9. Multislice spiral computed tomography (MSCT) | ||||||
10. Pain in the face | 10. High resolution computed tomography | ||||||
11. Erythema | 11. Abdominal computed tomography | ||||||
12. Development of eschar | 12. Paranasal computed tomography or MRI of the central nervous system (CNS) | ||||||
13. Infected and swollen eyelids | 13. In vivo confocal microscopy (IVCM) | ||||||
14. Irritation in the nose | 14. Tomographic imaging probe | ||||||
15. Consciousness loss | 15. Two-photon microscopy (TPM) | ||||||
16. A change in mental state | 16. PCR | ||||||
17. Hemiparesis | 17. DNA sequencing | ||||||
18. Convulsions | 18. Image-based automatic hyphae detection | ||||||
19. Double-sandwich (ds) ELISA | |||||||
Candida spp. | 1. Diploid | Causing candidiasis by | Clinical symptoms are | All candidiasis disease signs include | Diagnosis could be made by | [60] | |
2. Acquire dimorphism characteristic | 1. Adhering to epithelial cells | 1. Vulvovaginal candidiasis | 1. Discharge from the uterus | 1. Wet Mount | |||
3. Comprise filamentous hyphae | 2. Forming colonization | 2. Onychomycosis | 2. Irritation in the vaginal region | 2. PCR | |||
4. Secrets toxin | 3. Penetrating epithelia or invading hyphae | 3. Candidemia | 3. Burning sensation in the vagina | 3. Nucleic acid amplification tests (NAATs) | |||
4. Disseminating vascular tissue | 4. Intra-abdominal candidiasis | 4. Dyspareunia | 4. Mass spectrometry | ||||
5. Colonizing endothelia | 5. Peritonitis | 5. Dysuria | 5. 1,3-1β D glucan | ||||
6. Biliary candidiasis | 6. White patches emerge that resemble curd in the mouth, throat, tongue, and gum linings | 6. Mannan–antimannan | |||||
7. Candida endophthalmitis | 7. White lesions on the retinal surface | ||||||
8. Loss of vision, which may be gradual or occur suddenly | |||||||
9. Edema of the retina or papillary | |||||||
10. Inflammation and stricture development in both intrahepatic and extrahepatic biliary systems | |||||||
11. Vascular choroid | |||||||
12. Eyestrain, headaches, and floaters |